Skip to main content
Science|Business

Bringing together industry, research and policy

Menu
  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers
  • All
  • R&D Policy
    • Technology transfer
    • Horizon Europe
    • Start-ups
    • Brexit
    • International news
    • European Research Council
    • Universities
    • EU budget
    • Research and innovation gap
    • FP10
    • European Institute of Innovation and Technology
    • Intellectual property
    • Patents
    • European Research Area
    • European Innovation Council
    • SMEs
    • Research infrastructures
    • Partnerships
    • Planning FP10
    • Open science
    • Industry
    • Sovereignty
    • Missions
    • Cohesion policy
    • Careers
    • Basic science
    • Assessment
    • Erasmus
    • Synergies
  • Health
    • Drug development
    • Life sciences
    • COVID-19
    • Biotech
    • Vaccines
    • Clinical trials
    • Medical technology
    • Antimicrobial resistance
  • R&D Funding
  • Energy
    • Renewables
    • Hydrogen
    • Nuclear fusion
    • Batteries
    • Mobility
  • Digital
    • ICT
    • AI
    • Quantum computing
    • Data
    • Semiconductors
    • Super computers
    • Robotics
  • Climate
    • Green technology
    • Low-carbon
    • Circular economy
    • Agrifood
    • Biodiversity
    • Oceans
  • Defence
    • European Defence Fund
    • Dual use
    • Aerospace
    • Cybersecurity
    • European Space Agency
  • By Table.Media

Wellcome Trust urges CEOs to raise $8B for COVID-19 research

Wellcome Trust urges CEOs to raise $8B for COVID-19 research

Funding vaccine, drug and diagnostic development is the world’s one exit strategy from the pandemic

08 Apr 2020
Health
Research group to crowdsource compounds to test efficacy against COVID-19

Research group to crowdsource compounds to test efficacy against COVID-19

A €3M EU-funded research project is pulling together a ‘drug box’ from compound libraries around Europe for rapid screening against the crystal structure of the new coronavirus in some Europe’s largest supercomputers

03 Apr 2020
Health
Viewpoint: Hard lessons from COVID-19 will leave us better prepared for the next pandemic

Viewpoint: Hard lessons from COVID-19 will leave us better prepared for the next pandemic

This won’t be the last big global health crisis, warns Pierre Meulien, director of the EU’s Innovative Medicines Initiative

26 Mar 2020
Health
Combing Canada’s caves for new drugs

Combing Canada’s caves for new drugs

Armed with bear spray, microbiologist Naowarat ‘Ann’ Cheeptham is searching for hardy, less-studied bacteria that could play a role in stemming the antimicrobial resistance crisis

28 Mar 2019
Health
What the US elections means for climate change, tech, data privacy, drugs: some takeaways

What the US elections means for climate change, tech, data privacy, drugs: some takeaways

Congresswoman poised to become new House science chair pledges to ‘restore its credibility’

08 Nov 2018
R&D Policy
Drug prices row: EU health chief hits back at Trump view that Europe is ‘free-loading’ on US innovation

Drug prices row: EU health chief hits back at Trump view that Europe is ‘free-loading’ on US innovation

Vytenis Andriukaitis calls ‘fake news’ on Trump drug price blame game. Tariffs on medicines – if ever proposed by the US – would be ‘a humanitarian tragedy’, he says

21 Jun 2018
Health
New collaboration to engage patients in drug development for better health outcomes

New collaboration to engage patients in drug development for better health outcomes

Aim is to embed patient involvement - in setting research priorities, the design of clinical trials and dialogue with regulators and health technology assessment bodies - in health systems design

17 Apr 2018
Health

Imperial spin-out Photobiotics seals deal with pharma company

16 Dec 2010
News

Zealand triggers €500K milestone payment in deal with Helsinn

16 Dec 2010
News

Généthon agrees collaboration to manufacture gene therapy vectors

16 Dec 2010
News

Pagination

  • Previous page ‹‹
  • You're on Page 4
  • Next page ››

Get the Science|Business newsletters

newsletter iconReceive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 

  Sign up for the Funding Newswire

  Sign up for the Policy Bulletin

  Sign up for The Widening

Funding Newswire subscription

align-right

Follow where the public and private R&I money is going and which collaborative opportunities you can pursue. 

Subscribe today

Log in

Find out more about the Science|Business Network

Network iconA unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.

  Why join?

  Become a member

Home

Privacy   |   T&Cs   |   © 2025 Science Business Publishing Ltd.

  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers